What is a lung nodule and when does it need surgery?
A lung nodule is a small spot in the lung that is usually benign, but about one in five turn out to be cancer, so care is matched to estimated risk.
Covers: This page explains what a lung nodule is, how it is found and evaluated, and the factors that determine whether surgery or another intervention is needed. It does not cover the details of specific surgical techniques or treatment of confirmed lung cancer beyond the decision to operate.
Also answers: What is a lung nodule? · Lung nodule surgery criteria · Are lung nodules cancer? · Pulmonary nodule when to operate
- One page for this question6 other ways of asking lead here
- 5 independent sourcesEvery claim links to what supports it
- 2 connected pages2 changed this week
- Clean discussionScreened before anything appears
Before you read, make a guess
Fill in the blank: ?% of chest X-rays where nodules are found incidentally
Drag the slider to fill in the blank
The short answer
Evidence-backed AI-prepared starting mapA lung nodule (pulmonary nodule) is a relatively small focal density in the lung; a solitary pulmonary nodule is a mass smaller than three centimeters in diameter, and a micronodule is under three millimeters. Nodules are often found incidentally — in up to 0.2% of chest X-rays and around 1% of CT scans. Most are benign (for example granulomas or hamartomas), but roughly 20% represent malignant cancer, especially in older adults and smokers. Surgery is not the first step for most nodules: management is matched to estimated risk, with CT surveillance for low-risk nodules, PET-CT and/or biopsy for intermediate-risk nodules, and surgical resection reserved for selected high-risk nodules.12
- Evidence 23
Did this answer your question?
Be the first to voteIn brief
A lung nodule is a small focal density in the lung; a solitary nodule is under three centimeters, and a micronodule is under three millimeters.1
Evidence-backedMost nodules are benign, but around 20% represent malignant cancer, especially in older adults and smokers.1
Evidence-backedSurgery is reserved for selected high-risk nodules; low-risk nodules are usually followed with CT surveillance and intermediate-risk nodules with PET-CT and/or biopsy.2
Evidence-backedComparing a nodule with previous imaging, and knowing whether it is solid or subsolid, are central to judging risk.2
Evidence-backedThe goal of management is to diagnose cancer promptly while avoiding unnecessary invasive procedures in people with benign disease.2
Evidence-backed
At a glance
The picture in numbers
Live · updated just now
0.2%
about 1 in every 500
1%
about 1 in every 100
20%
20 in every 100
The evidence behind it
5 sources- Reviews of many studies1
- Other studies and data2
- Background2
Published in 2026
| Source | Kind | Year |
|---|---|---|
| Pulmonary Nodules. | Other studies and data | 2026 |
| Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives. | Reviews of many studies | 2026 |
| Lung nodule (Wikipedia) | Background | Unknown |
| Pope Leo to have surgery after lump found on lung | Background | 2026 |
| ACR Appropriateness Criteria® Indolent Lung Cancer. | Other studies and data | 2026 |
The community around it
No one has added to this page yet. Firsthand experience, a newer study or a different reading of the numbers would show up here, credited to you.
What it means for you
Which fits you?
Pick the situation closest to yours. Each answer says what it rests on.
If a nodule is solid and has been stable for two years
it is considered benign, so surgery is generally not needed on that basis.2
Evidence-backedIf a nodule is subsolid
it needs a longer period of stability than a solid nodule before it is considered benign, and it carries a higher risk of malignancy, especially if a solid component develops or enlarges.2
Evidence-backedIf the nodule is judged low risk
CT surveillance is the indicated approach.2
Evidence-backedIf the nodule is judged intermediate risk
PET-CT, biopsy, or both are indicated.2
Evidence-backedIf the nodule is judged high risk and selected for resection
surgical resection is the management option described.2
Evidence-backedIf you have a history of smoking or the nodule is growing
the possibility of cancer may need to be excluded through further radiological studies and interventions, possibly including surgical resection.1
Evidence-backedIf your clinical team has decided to delay intervention
imaging surveillance follows separate evidence-based guidance, and a diagnostic workup or biopsy would be considered part of treatment rather than surveillance.4
Evidence-backedThe full story · 3 chapters
01
What a lung nodule is and how it is found
AI summary:A lung nodule is a small focal density in the lung, often found incidentally on chest X-rays or CT scans, and most are benign.
Evidence-backed: A lung nodule, or pulmonary nodule, is a relatively small focal density in the lung. A solitary pulmonary nodule (sometimes called a coin lesion) is a mass in the lung smaller than three centimeters in diameter; a pulmonary micronodule is less than three millimeters across. There may also be multiple nodules. One or more nodules can be an incidental finding, appearing in up to 0.2% of chest X-rays and around 1% of CT scans.1
Evidence-backed: Incidental detection is increasing as imaging techniques improve and CT scans are used more widely for thoracic evaluation. Most incidental pulmonary nodules are benign, but some represent early-stage lung cancer, which is why telling benign from malignant nodules apart is central to improving lung cancer outcomes.3
Evidence-backed: The nodule most commonly represents a benign tumor such as a granuloma or hamartoma, but in around 20% of cases it represents a malignant cancer, especially in older adults and smokers. Conversely, 10 to 20% of patients with lung cancer are diagnosed in this way.1
02
How the risk that a nodule is cancer is assessed
AI summary:Risk of cancer is judged by comparing with previous imaging, watching for growth, and noting whether the nodule is solid or subsolid.
Evidence-backed: Comparing current imaging with previous studies, when available, is essential to assess the risk of a nodule being malignant. Solid nodules that have been stable for two years are considered benign, whereas subsolid nodules need a longer period of stability before they are considered benign. Prediction models that stratify the risk of malignancy can be used to guide management of solid nodules.2
Evidence-backed: Subsolid nodules are often slower growing than solid nodules but carry a higher risk of being malignant, especially if a solid component develops or progressively enlarges.2
Evidence-backed: A history of smoking, or a nodule that is growing, may mean the possibility of cancer needs to be excluded through further radiological studies and interventions, possibly including surgical resection. The prognosis depends on the underlying condition.1
03
When surgery is considered
AI summary:Management is matched to risk: CT surveillance for low risk, PET-CT or biopsy for intermediate risk, and surgery for selected high-risk nodules.
Evidence-backed: Management is matched to estimated risk. CT surveillance is indicated for low-risk nodules; PET-CT, biopsy, or both for intermediate-risk nodules; and surgical resection for selected high-risk nodules. Biopsy methods include transthoracic needle biopsy and navigational bronchoscopy. Optimal overall management balances timely diagnosis in people who have cancer against avoiding unnecessary invasive procedures in people who have benign disease.2
Evidence-backed: Current management guidelines differ by nodule type and involve biopsy to determine whether a nodule is malignant.3
Evidence-backed: When a clinical team decides that treatment is necessary, a diagnostic imaging workup and a biopsy are typically indicated and should not be considered part of surveillance. Separate evidence-based guidance exists for imaging surveillance of indolent nodules in patients whose team has chosen to delay intervention.4
Evidence-backed: A recent news example illustrates the early-detection framing: a 71-year-old pontiff was reported to be having surgery after a nodule was found on his lung, which he said was identified "at a very early stage." This is a single reported case and does not by itself indicate when surgery is appropriate.5
Your turn
Have your say
See where others stand. Join free to add your perspective. One answer per account.
How do you feel about this?
No votes yetQuick questions from connected pages
Before you go
What to remember
Try to recall each hidden figure before you reveal it. Remembering, not rereading, is what makes it stick.
Most nodules are benign, but around represent malignant cancer, especially in older adults and smokers.
A lung nodule is a small focal density in the lung; a solitary nodule is under three centimeters, and a micronodule is under three millimeters.
Surgery is reserved for selected high-risk nodules; low-risk nodules are usually followed with CT surveillance and intermediate-risk nodules with PET-CT and/or biopsy.
Your reading
0 of 3 chaptersThis answer keeps changing
When new evidence or a better source comes in, this page is updated (it's on version 2, last changed 48 minutes ago). Follow it to be told when that happens.
Ask this Sylo
Still wondering about something?
Answers come only from this page's reviewed material, with citations, and say plainly when the page doesn't cover it yet.
Behind this page
Who's adding to it, where it comes from, how it changed and what would make it better. Always open to everyone.
Discussion
Sources
Numbers match the citations in the article. A working link isn't proof that a page supports a claim; check the quoted passage and date.
- 1Lung nodule (Wikipedia)WikipediaPublished Sep 29, 2026Checked Oct 11, 2026
“A lung nodule or pulmonary nodule is a relatively small focal density in the lung. A solitary pulmonary nodule (SPN) or coin lesion, is a mass in the lung smaller than three centimeters in diameter. A pulmonary micronodule has a diameter of less than three millimetres. There may also be multiple nodules. One or more lung nodules can be an incidental finding found in up to 0.2% of chest X-rays and around 1% of CT scans. The nodule most commonly represents a benign tumor such as a granuloma or hamartoma, but in around 20% of cases it represents a malignant cancer, especially in older adults and smokers. Conversely, 10 to 20% of patients with lung cancer are diagnosed in this way. If the patient has a history of smoking or the nodule is growing, the possibility of cancer may need to be excluded through further radiological studies and interventions, possibly including surgical resection. The prognosis depends on the underlying condition.”
- 2Pulmonary Nodules.The New England journal of medicine (Callister & Silvestri)Published Sep 1, 2026Checked Oct 11, 2026
“Management strategies differ according to the type of nodule. A comparison of current and previous imaging studies, when available, is essential to assess the risk of the nodule being malignant. Solid nodules that have been stable for 2 years are considered to be benign, whereas subsolid nodules require a longer period of stability to be considered benign. Prediction models to stratify the risk of the nodule being malignant can be used to guide the management of solid nodules. Computed tomographic (CT) surveillance is indicated for low-risk nodules; positron-emission tomography-CT, biopsy, or both for intermediate-risk nodules; and surgical resection for selected high-risk nodules. Subsolid nodules are often slower growing than solid nodules but are associated with a higher risk of being malignant, especially if a solid component develops or progressively enlarges. Biopsy methods include transthoracic needle biopsy and navigational bronchoscopy. Optimal overall management balances timely diagnosis in persons who have cancer with the avoidance of unnecessary invasive procedures in persons who have benign disease.”
- 3Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives.Lung cancer (Amsterdam, Netherlands) (Soo et al.)Published Aug 3, 2026Checked Oct 11, 2026
“Lung cancer is the leading cause of cancer-related deaths globally, and early diagnosis and treatment are important for improving prognosis. Pulmonary nodules (PNs) are small pulmonary lesions frequently identified during clinical practice, with incidental detection increasing due to advances in imaging techniques and the expanded use of computed tomography scans for thoracic evaluation. The majority of incidental PNs (IPNs) are benign, however some represent early-stage lung cancer, therefore distinguishing benign from malignant IPNs is key to improving lung cancer outcomes. Current management guidelines differ by nodule type and involve biopsy to determine the malignancy status of the nodule. Here, we review current knowledge on the classification, prevalence, and detection of PNs, as well as the current management and risk stratification of PNs. We outline the role of oncogenic driver mutations in the pathobiology of PNs and assess current literature on targeted treatment of oncogene-driven PNs. Finally, we discuss evidence gaps and areas for future research.”
- 4ACR Appropriateness Criteria® Indolent Lung Cancer.Journal of the American College of Radiology : JACR (Expert et al.)Published Aug 10, 2026Checked Oct 11, 2026
“If the team determines that treatment is necessary, a diagnostic imaging workup and a biopsy are typically indicated and should not be considered part of surveillance. Therefore, this document aims to outline evidence-based guidelines specifically for imaging surveillance of indolent pulmonary nodules in patients for whom the clinical team has chosen to delay intervention. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.”
- 5Pope Leo to have surgery after lump found on lungBBC NewsPublished Oct 11, 2026Checked Oct 11, 2026
“The 71-year-old pontiff said the nodule was identified "at a very early stage".”
How it changed
Published 1 time since Oct 11, 2026.
- Version 2Oct 11, 2026Live now
AI-prepared Starting Map from live research.
- First published version.
Help improve it
The brief is open about what's uncertain. These are the specific gaps that new material would fill.
Open questions
What specific nodule sizes, growth rates or risk-model scores define low, intermediate and high risk in current guidelines?
No answers yet
How long must a subsolid nodule remain stable before it is considered benign, and how does that compare with the two-year rule for solid nodules?
No answers yet
For high-risk nodules that go to surgery, what proportion turn out to be cancer, and what are the harms of operating on benign nodules?
No answers yet
What is the current evidence on targeted treatment of oncogene-driven pulmonary nodules, and where are the main gaps?
No answers yet
Around this topic
Sylos connect: narrower topics report up to broader ones, so what's learned in one place shows up where it matters.